CVS Lets Down Wall Street With Reaffirmed Profit Guidance (3)

CVS Health Corp. disappointed Wall Street by reiterating its profit guidance for 2026, a move analysts are calling a letdown after a strong fourth-quarter performance.

The company said it still sees 2026 adjusted earnings of $7 to $7.20 a share. The midpoint was below the average analyst estimate of $7.17 a share.

CVS fell as much as 3.7% when markets opened in New York on Tuesday before paring losses.

The reaffirmed guidance failed to clear the bar the market set for CVS, analysts from Leerink Partners and TD Cowen wrote in separate notes. The company is taking a cautious approach ...